Martel Wealth Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Martel Wealth Advisors's EW Position: Q3 2026 in Review
Martel Wealth Advisors sold out of Edwards Lifesciences (EW) in Q3 2026, closing a stake of 2,400 shares — an estimated $217K sold.
Martel Wealth Advisors first reported a position in EW in Q2 2023 and held it in 6 quarters. The position peaked at $229K in Q1 2024. 1,270 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Martel Wealth Advisors reported no remaining Edwards Lifesciences position as of Q3 2026 after selling out during the quarter.
- Martel Wealth Advisors sold 2,400 Edwards Lifesciences shares in Q3 2026, an estimated $217K.
- Martel Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2023 and held it in 6 quarters.
- Martel Wealth Advisors's Edwards Lifesciences position peaked at $229K in Q1 2024.
- 1,270 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Martel Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.